StockData
LifeStance Health Group, Inc. logo

LifeStance Health Group, Inc. (LFST) stock

LFSTNasdaqServices-Health ServicesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 12/30139% above fair value
$14.08−0.07 (-0.49%)

Close on Nov 13, 2026Market cap $5.38BP/E 74.1Yield –

LifeStance Health operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

LifeStance Health's operating cash flow for the twelve months ending Sep 30, 2026 was $227.60M, up 50.8% year over year. For fiscal 2025 it was $146.15M, up 36.3% from the year before. The highest annual figure on record is $146.15M in fiscal 2025.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025$146.15M+36.3%
FY2024Dec 31, 2024$107.26M–
FY2023Dec 31, 2023-$16.88M-132.0%
FY2022Dec 31, 2022$52.79M+460.4%
FY2021Dec 31, 2021$9.42M-44.7%
FY2019Dec 31, 2019$17.05M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$37.02M+35.7%
Q2 FY2026Jun 30, 2026$99.91M+55.2%
Q1 FY2026Mar 31, 2026$33.11M–
Q4 FY2025Dec 31, 2025$57.56M-7.6%
Q3 FY2025Sep 30, 2025$27.29M+20.1%
Q2 FY2025Jun 30, 2025$64.40M+46.2%
Q1 FY2025Mar 31, 2025-$3.09M–
Q4 FY2024Dec 31, 2024$62.32M+271.0%
Q3 FY2024Sep 30, 2024$22.72M–
Q2 FY2024Jun 30, 2024$44.06M–
Q1 FY2024Mar 31, 2024-$21.84M–
Q4 FY2023Dec 31, 2023$16.80M-53.2%
Q3 FY2023Sep 30, 2023-$25.36M-542.5%
Q2 FY2023Jun 30, 2023-$434.00K-105.5%
Q1 FY2023Mar 31, 2023-$7.89M-338.5%
Q4 FY2022Dec 31, 2022$35.92M+17.2%
Q3 FY2022Sep 30, 2022$5.73M–
Q2 FY2022Jun 30, 2022$7.83M–
Q1 FY2022Mar 31, 2022$3.31M-66.6%
Q4 FY2021Dec 31, 2021$30.64M–
Q3 FY2021Sep 30, 2021-$14.21M–
Q2 FY2021Jun 30, 2021-$16.92M–
Q1 FY2021Mar 31, 2021$9.91M–
Q2 FY2020Jun 30, 2020-$37.32M–

More LifeStance Health figures

See a number that looks wrong?